Flavonoids as substrates and inhibitors of myeloperoxidase: Molecular actions of aglycone and metabolites

Chemical Research in Toxicology

Volumn 21, Issue 8, 2008, Pages 1600-1609

  Shiba, Yuko ^a   Kinoshita, Takashi ^b   Chuman, Hiroshi ^b   Taketani, Yutaka ^a   Takeda, Eiji ^a   Kato, Yoji ^c   Naito, Michitaka ^d   Kawabata, Kyuichi ^a   Ishisaka, Akari ^a   Terao, Junji ^a   Kawai, Yoshichika ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c UNIVERSITY OF HYOGO   (Japan)

^d SUGIYAMA JOGAKUEN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGLYCONE; FLAVONOID; MYELOPEROXIDASE; QUERCETIN; TYROSINE;

ARTICLE; ATHEROSCLEROSIS; CALCULATION; CATALYSIS; CHEMICAL BOND; CHEMICAL REACTION; HUMAN; HUMAN CELL; HYDROPHOBICITY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; STRUCTURE ACTIVITY RELATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; AORTA; ATHEROSCLEROSIS; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FREE RADICAL SCAVENGERS; HL-60 CELLS; HUMANS; MACROPHAGES; PEROXIDASE; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; QUERCETIN; RATS; RATS, INBRED STRAINS; TYROSINE;

EID: 51449084637     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx8000835     Document Type: Article

References (51)

1. Heinecke, J. W., Li, W., and Goldstein, J. A. (1993) Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidasehydrogen peroxide system of human neutrophils and macrophages. J. Biol. Chem. 268, 4069-4077.
2. Nakagawara, A., Nathan, C. F., and Cohn, Z. A. (1981) Hydrogen peroxide metabolism in human monocytes during differentiation in vitro. J. Clin. Invest. 68, 1243-1252.
3. Hazen, S. L., and Heinecke, J. W. (1997) 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest. 99, 2075-2081.
4. Thukkani, A. K., McHowat, J., Hsu, F. F., Brennan, M. L., Hazen, S. L., and Ford, D. A. (2003) Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions. Circulation 108, 3128-3133.
5. Henderson, J. P., Byun, J., Takeshita, J., and Heinecke, J. W. (2003) Phagocytes produce 5-chlorouracil and 5-bromouracil, two mutagenic products of myeloperoxidase, in human inflammatory tissue. J. Biol. Chem. 278, 23522-23528.
6. Kawai, Y., Morinaga, H., Kondo, H., Miyoshi, N., Nakamura, Y., Uchida, K., and Osawa, T. (2004) Endogenous formation of novel halogenated 2′-deoxycytidine. Hypohalous acid-mediated DNA modification at the site of inflammation. J. Biol. Chem. 279, 51241-51249.
7. Kawai, Y., Kiyokawa, H., Kimura, Y., Kato, Y., Tsuchiya, K., and Terao, J. (2006) Hypochlorous acid-derived modification of phospholipids: characterization of aminophospholipids as regulatory molecules for lipid peroxidation. Biochemistry 45, 14201-14211.
8. Hori, H., Fenna, R. E., Kimura, S., and Ikeda-Saito, M. (1994) Aromatic substrate molecules bind at the distal heme pocket of myeloperoxidase. J. Biol. Chem. 269, 8388-8392.
9. Davey, C. A., and Fenna, R. E. (1996) 2.3 A resolution X-ray crystal structure of the bisubstrate analogue inhibitor salicylhydroxamic acid bound to human myeloperoxidase: a model for a prereaction complex with hydrogen peroxide. Biochemistry 35, 10967-10973.
10. Byun, J., Henderson, J. P., Mueller, D. M., and Heinecke, J. W. (1999) 8-Nitro-2′-deoxyguanosine, a specific marker of oxidation by reactive nitrogen species, is generated by the myeloperoxidase-hydrogen peroxide-nitrite system of activated human phagocytes. Biochemistry 38, 2590-2600.
11. Zhang, R., Shen, Z., Nauseef, W. M., and Hazen, S. L. (2002) Defects in leukocyte-mediated initiation of lipid peroxidation in plasma as studied in myeloperoxidase-deficient subjects: systematic identification of multiple endogenous diffusible substrates for myeloperoxidase in plasma. Blood 99, 1802-1810.
12. Leeuwenburgh, C., Rasmussen, J. E., Hsu, F. F., Mueller, D. M., Pennathur, S., and Heinecke, J. W. (1997) Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J. Biol. Chem. 272, 3520-3526.
13. Leeuwenburgh, C., Hardy, M. M., Hazen, S. L., Wagner, P., Oh-ishi, S., Steinbrecher, U. P., and Heinecke, J. W. (1997) Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J. Biol. Chem. 272, 1433-1436.
14. Beckmann, J. S., Ye, Y. Z., Anderson, P. G., Chen, J., Accavitti, M. A., Tarpey, M. M., and White, C. R. (1994) Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol. Chem. Hoppe-Seyler 375, 81-88.
15. McMillen, T. S., Heinecke, J. W., and LeBoeuf, R. C. (2005) Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice. Circulation 111, 2798-2804.
16. - system of neutrophils by indomethacin and other non-steroidal anti-inflammatory drugs. Biochem. Pharmacol. 41, 975-984.
17. Kettle, A. J., and Winterbourn, C. C. (1991) Mechanism of inhibition of myeloperoxidase by anti-inflammatory drugs. Biochem. Pharmacol. 41, 1485-1492.
18. Hertog, M. G., Feskens, E. J., Hollman, P. C., Katan, M. B., and Kromhout, D. (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342, 1007-1011.
19. Hertog, M. G., Feskens, E. J., Hollman, P. C., Katan, M. B., and Kromhout, D. (1994) Dietary flavonoids and cancer risk in the Zutphen Elderly Study. Nutr. Cancer 22, 175-184.
20. Hertog, M. G., Kromhout, D., Aravanis, C., Blackburn, H., Buzina, R., Fidanza, F., Giampaoli, S., Jansen, A., Menotti, A., Nedeljkovic, S., Pekkarinen, M., Simic, B. S., Toshima, H., Feskens, E. J. M., Hollman, P. C. H., and Katan, M. B. (1995) Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch. Intern. Med. 155, 381-386.
21. Hertog, M. G., and Hollman, P. C. (1996) Potential health effects of the dietary flavonol quercetin. Eur. J. Clin. Nutr. 50, 63-71.
22. Keli, S. O., Hertog, M. G., Feskens, E. J., and Kromhout, D. (1996) Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch. Intern. Med. 156, 637-642.
23. Le Marchand, L., Murphy, S. P., Hankin, J. H., Wilkens, L. R., and Kolonel, L. N. (2000) Intake of flavonoids and lung cancer. J. Natl. Cancer Inst. 92, 154-160.
24. Kawai, Y., Nishikawa, T., Shiba, Y., Saito, S., Murota, K., Shibata, N., Kobayashi, M., Kanayama, M., Uchida, K., and Terao, J. (2008) Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: Implication in the anti-atherosclerotic mechanism of dietary flavonoids. J. Biol. Chem. 283, 9424-9434.
25. Pincemail, J., Deby, C., Thirion, A., de Bruyn-Dister, M., and Goutier, R. (1988) Human myeloperoxidase activity is inhibited in vitro by quercetin. Comparison with three related compounds. Experientia 44, 450-453.
26. Kato, Y., Nagao, A., Terao, J., and Osawa, T. (2003) Inhibition of myeloperoxidase-catalyzed tyrosylation by phenolic antioxidants in vitro. Biosci. Biotechnol. Biochem. 67, 1136-1139.
27. Murota, K., and Terao, J. (2003) Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch. Biochem. Biophys. 417, 12-17.
28. Day, A. J., Mellon, F., Barron, D., Sarrazin, G., Morgan, M. R., and Williamson, G. (2001) Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radical Res. 35, 941-952.
29. Moon, J. H., Tsushida, T., Nakahara, K., and Terao, J. (2001) Identification of quercetin 3-O-beta-D-glucuronide as an antioxidative metabolite in rat plasma after oral administration of quercetin. Free Radical Biol. Med. 30, 1274-1285.
30. Kato, Y., Wu, X., Naito, M., Nomura, H., Kitamoto, N., and Osawa, T. (2000) Immunochemical detection of protein dityrosine in atherosclerotic lesion of apo-E-deficient mice using a novel monoclonal antibody. Biochem. Biophys. Res. Commun. 275, 11-15.
31. Marquez, L. A., and Dunford, H. B. (1995) Kinetics of oxidation of tyrosine and dityrosine by myeloperoxidase compounds I and II. Implications for lipoprotein peroxidation studies. J. Biol. Chem. 270, 30434-30440.
32. van Dalen, C. J., Winterbourn, C. C., Senthilmohan, R., and Kettle, A. J. (2000) Nitrite as a substrate and inhibitor of myeloperoxidase. Implications for nitration and hypochlorous acid production at sites of inflammation. J. Biol. Chem. 275, 11638-11644.
33. Liu, X., Tanaka, H., Yamauchi, A., Testa, B., and Chuman, H. (2005) Determination of lipophilicity by reversed-phase high-performance liquid chromatography. Influence of 1-octanol in the mobile phase. J. Chromatogr., A. 1091, 51-59.
34. Daugherty, A., Dunn, J. L., Rateri, D. L., and Heinecke, J. W. (1994) Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94, 437-444.
35. Kamada, C., da Silva, E. L., Ohnishi-Kameyama, M., Moon, J. H., and Terao, J. (2005) Attenuation of lipid peroxidation and hyperlipidemia by quercetin glucoside in the aorta of high cholesterol-fed rabbit. Free Radical Res. 39, 185-194.
36. Sakakibara, H., Ashida, H., and Kanazawa, K. (2002) A novel method using 8-hydroperoxy-2′-deoxyguanosine formation for evaluating antioxidative potency. Free Radical Res. 36, 307-316.
37. Marquez, L. A., Huang, J. T., and Dunford, H. B. (1994) Spectral and kinetic studies on the formation of myeloperoxidase compounds I and II: roles of hydrogen peroxide and superoxide. Biochemistry 33, 1447-1454.
38. Boersma, M. G., Vervoort, J., Szymusiak, H., Lemanska, K., Tyrakowska, B., Cenas, N., Segura-Aguilar, J., and Rietjens, I. M. (2000) Regioselectivity and reversibility of the glutathione conjugation of quercetin quinone methide. Chem. Res. Toxicol. 13, 185-191.
39. Thavasi, V., Leong, L. P., and Bettens, R. P. (1996) Investigation of the influence of hydroxy groups on the radical scavenging ability of polyphenols. J. Phys. Chem. A 110, 4918-4923.
40. Zsila, F., Bikadi, Z., and Simonyi, M. (2003) Probing the binding of the flavonoid, quercetin to human serum albumin by circular dichroism, electronic absorption spectroscopy and molecular modelling methods. Biochem. Pharmacol. 65, 447-456.
41. Qin, C., Xie, M. X., and Liu, Y. (2007) Characterization of the myricetin-human serum albumin complex by spectroscopic and molecular modeling approaches. Biomacromolecules 8, 2182-2189.
42. Mahesha, H. G., Singh, S. A., Srinivasan, N., and Rao, A. G. (2006) A spectroscopic study of the interaction of isoflavones with human serum albumin. FEBS J. 273, 451-467.
43. Galijasevic, S., Abdulhamid, I., and Abu-Soud, H. M. (2008) Melatonin is a potent inhibitor for myeloperoxidase. Biochemistry 47, 2668-2677.
44. Harborne, J. B., Mabry, T. J., and Mabry, H. (1975) Academic Press, New York.
45. Harborne, J. B. (1986) Nature, distribution and function of plant flavonoids. Prog. Clin. Biol. Res. 213, 15-24.
46. Kinoshita, T., Lepp, Z., and Chuman, H. (2005) Construction of a novel database for flavonoids. J. Med. Invest. 52, 291-292.
47. Kinoshita, T., Lepp, Z., Kawai, Y., Terao, J., and Chuman, H. (2006) An integrated database of flavonoids. Biofactors 26, 179-188.
48. Bergt, C., Pennathur, S., Fu, X., Byun, J., O'Brien, K., McDonald, T. O., Singh, P., Anantharamaiah, G. M., Chait, A., Brunzell, J., Geary, R. L., Oram, J. F., and Heinecke, J. W. (2004) The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc. Natl. Acad. Sci. U.S.A. 101, 13032-13037.
49. Wu, Z., Wagner, M. A., Zheng, L., Parks, J. S., 3rd, Smith, J. D., Gogonea, V., and Hazen, S. L. (2007) The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction. Nat. Struct. Mol. Biol. 14, 861-868.
50. D'Alessandro, T., Prasain, J., Benton, M. R., Botting, N., Moore, R., Darley-Usmar, V., Patel, R., and Barnes, S. (2003) Polyphenols, inflammatory response, and cancer prevention: chlorination of isoflavones by human neutrophils. J. Nutr. 133, 3773S-3777S.
51. Binsack, R., Boersma, B. J., Patel, R. P., Kirk, M., White, C. R., Darley-Usmar, V., Barnes, S., Zhou, F., and Parks, D. A. (2001) Enhanced antioxidant activity after chlorination of quercetin by hypochlorous acid. Alcohol.: Clin. Exp. Res. 25, 434-443.